Form 4: Clene Inc. Director Matthew Kiernan Acquires Stock Options
SEC Form 4
Director Matthew Kiernan acquired stock options for 30,000 shares of Clene Inc. common stock on May 29, 2024.
Summary
- On May 29, 2024, Matthew Kiernan, a director of Clene Inc., was granted stock options to purchase 30,000 shares of the company's common stock.
- The exercise price for these options is $0.37 per share.
- The options vest in 12 equal monthly installments starting June 29, 2024, and expire on May 28, 2034.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a transaction. The grant of options to a director can be seen as a mildly positive sign, reflecting confidence in the company's future.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities by a company insider. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- Shareholders may view the granting of stock options to a director as a way to align management's interests with their own.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction: Matthew Kiernan acquired stock options. |
| 06/29/2024 | Vesting start date: Options vest in 12 equal monthly installments starting this date. |
| 05/28/2034 | Expiration date: Options expire on this date. |
| 05/31/2024 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.